Anti-thrombin anticoagulant aptamers act as dual-targeting agents by recognizing both thrombin and its precursor, prothrombin. Biophysical and structural analyses reveal a similar recognition mechanism and suggest that aptamer binding shifts prothrombin toward its open conformation, providing new insights for the rational design of next-generation anticoagulant therapeutics.